State Of Wisconsin Investment Board Taysha Gene Therapies, Inc. Transaction History

State Of Wisconsin Investment Board

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.76 - $4.94 $42,064 - $118,066	-23,900 Reduced 21.63%	86,600 $167,000
Q2 2022 Aug 15, 2022	BUY	$2.47 - $6.77 $18,278 - $50,098	7,400 Added 7.18%	110,500 $411,000
Q1 2022 May 13, 2022	BUY	$5.22 - $11.86 $387,846 - $881,198	74,300 Added 257.99%	103,100 $672,000
Q2 2021 Aug 12, 2021	BUY	$19.29 - $26.38 $555,552 - $759,744	28,800 New	28,800 $611,000

117

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $85.1M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.